Answer
Briumvi (ublituximab) treats adults with relapsing forms of multiple sclerosis with active disease defined by clinical or imaging features.
Sources for this answer
- Briumvi 150 mg concentrate for solution for infusionNeuraxpharm UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated
Sources checked